Validation of the Probiotic Concept: Lactobacillus reuteri confers broad-spectrum protection against disease in humans and animals

Microbial Ecology in Health and Disease

Volumn 12, Issue 4, 2000, Pages 247-285

  Casas, I A ^a   Dobrogosz, W J ^b  

^a BioGaia Biologics Inc   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; CHOLESTEROL; CYTOKINE; METHOTREXATE; PROBIOTIC AGENT;

BACTERIAL COLONIZATION; BACTERIAL FLORA; BACTERIAL TRANSLOCATION; CHOLESTEROL BLOOD LEVEL; COLD STRESS; CYTOKINE PRODUCTION; DIARRHEA; ENTEROCOLITIS; HOST PARASITE INTERACTION; IMMUNITY; INTESTINE FLORA; INTESTINE VILLUS; LACTOBACILLUS REUTERI; LAMINA PROPRIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REVIEW; ROTAVIRUS; SALMONELLA TYPHIMURIUM; STRAIN DIFFERENCE; SYMBIOSIS; VALIDATION PROCESS;

ANIMALIA; AVES; BACILLI; BACTERIA (MICROORGANISMS); FUNGI; LACTOBACILLUS REUTERI; MAMMALIA; MICROBIOTA; PROTOZOA; ROTAVIRUS; SALMONELLA TYPHIMURIUM; TYPHIMURIUM; VERTEBRATA;

EID: 0034515202     PISSN: 0891060X     EISSN: None     Source Type: Journal    
DOI: 10.1080/08910600050216246-1     Document Type: Review

References (253)

1. Factors affecting the microecology of the gut
2. The present status of the Nurmi concept for reducing carriage of food poisoning salmonellae and other pathogens in poultry
3. Gut flora and disease resistance
4. Genetic manipulation of gut microorganisms
5. Probiotics: A general view
6. Probiotics for chickens
7. Enumeration and identification of lactobacilli in dietary products
8. Probiotics, prebiotics or 'conbiotics'?
9. Probiotic bacteria: Myth or reality
10. The scientific basis for probiotic strains of Lactobacillus
11. Probiotic spectra of lactic acid bacteria (LAB)
12. Lactobacillus reuteri: An effective probiotic for poultry and other animals
13. Lactobacillus reuteri: An overview of a new probiotic for humans and animals
14. Creating and maintaining the gastrointestinal ecosystem: What we know and need to know from gnotobiology
15. Ueber antagonisten unter den bacterien
16. Elie Metchnikoff's Bacillus of long life
17. Effect of streptomycin in susceptibility of intestinal tract to experimental Salmonella infection
18. Fatal enteric cholera infection in the guinea pig achieved by inhibition of the normal enteric flora
19. The microecology of Clostridium difficile
20. New aspects of Salmonella infection in broiler production
21. Protecting chicks and poults from salmonellae by oral administration of normal gut microflora
22. Competitive exclusion of intestinal colonization of Escherichia coli in chicks
23. Intestinal colonization and competitive exclusion of Campylobacter fetus subsp. jejuni in young chicks
24. Comparative studies on competitive exclusion of three isolates of Campylobacter fetus subsp. jejuni in chickens by native gut microflora
25. Competitive exclusion of some pathogens other than salmonellae by native intestinal microflora of chickens
26. Establishment and competitive exclusion of Yersenia enterocolitica in the gut of monoxenic and holoxenic chickens
27. Competitive exclusion of salmonellas from the chick caecum using a defined mixture of bacterial isolates from the caecal microflora of an adult bird
28. Growth of salmonellae in orally infected germfree mice
29. Lactobacilus reuteri sp. nov. a new species of heterofermentative lactobacilli
30. Das vorkommen von laktobazillen in lebensmitteln und ihr verhalten im menschlichen intestinaltrakt
31. Das vorkommen aerob wachsender grampositiver stabchen des genus Lactobacuillus beijerinck im darminhalt erwachsener menchen
32. Regular nonsporing gram positive rods
33. Lactic acid bacteria: Classification and physiology
34. Characterization and DNA homology of Lactobacillus reuteri strains isolated from pig intestine
35. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes
36. Selection and design of probiotics
37. Classification of citratefermenting lactobacilli isolated from lamb stomach, sheep milk, and pecorino romano cheese
38. Identification and characteristics of lactic acid bacteria isolated from sour dough sponges
39. Identification of lactobacilli from sourdough and description of Lactobacillus pontis sp. nov.
40. Identification of lactic acid bacteria isolated from fermented rice noodle khanom jeen of Thailand. Studies on the red orange pigment producing lactic acid bacteria L 622 in the fermented rice noodle khanom jeen of Thailand
41. Production of succinic acid from citric acid and related acids by Lactobacillus strains
42. Numerical taxonomy of Lactobacillus spp. associated to healthy and diseased mucosa of the human intestines
43. Taxonomy of lactobacilli isolated from the alimentary tract of chickens
44. Lactobacillus reuteri and the enteric microbiota
45. Development of intestinal lactobacilli in normal piglets
46. Systematics of the Lactobacillus population on rat mucosa with special reference to Lactobacillus reuteri
47. The antagonistic properties of microaerophilic bacteria isolated from the human and mink digestive tracts
48. The human gastrointestinal tract
49. Lactobacilli in human feces
50. Taxonomy of the Lactobacillus acidophilus group
51. Effect of host-specific Lactobacillus reuteri on ileal tissue development in gnotobiotic BALB/c mice
52. Lactobacillus reuteri: Presence during early age of infants
53. Probiotic administrations of Lactobacillus reuteri moderate avian growth depression in turkeys
54. Principles of ex ovo competitive exclusion and in ovo administration of Lactobacillus reuteri
55. Avian growth depression in chickens induced by environmental, microbiological, or nutritional stress is moderated by probiotic administrations of Lactobacillus reuteri
56. The effect of administration of Lactobacillus reuteri on the establishmental pattern of a normal intestinal microflora in rats
57. Microflora-associated characteristics (MACs) and germfree animal characteristics (GACs) in man and animals
58. Establishment of a biochemically active intestinal ecosystem in ex-germfree rats
59. How conventional are conventional animals after long-term maintenance under barrier conditions?
60. Role of intestinal bacteria in nutrient metabolism
61. Probiotic treatment with Lactobacillus reuteri protects commercial turkeys from avian growth depression
62. Performance of GAIAfeed® and GAIAspray®: A Lactobacillus reuteri-based probiotic for poultry
63. Lactic acid bacteria: Classification and physiology
64. Production of a broad spectrum antimicrobial substance by Lactobacillus reuteri
65. In vitro studies on reuterin synthesis by Lactobacillus reuteri
66. Chemical characterization of an antimicrobial substance produced by Lactobacillus reuteri
67. Purification and characterization of glycerol dehydratase from Lactobacillus reuteri
68. Utilization of glycerol as a hydrogen acceptor by Lactobacillus reuteri: Purification of 1,3-propanediol: NAD oxidoreductase
69. Enhancement of 1,3-propanediol production by cofermentation in Escherichia coli expressing Klebsiella pneumonia dha regulon genes
70. Characterization of growth and metabolite production of Lactobacillus reuteri during glucose/glycerol cofermentations in batch and continuous cultures
71. The effect of reuterin on Listeria monocytogenes and Escherichia coli O157:H7 in milk and cottage cheese
72. Application of reuterin produced by Lactobacillus reuteri 12002 for meat decontamination and preservation
73. Antagonistic activities of lactic acid bacteria in food and feed fermentations
74. Antimicrobial substances from lactic acid bacteria for use as food preservatives
75. Intestinal effects of the products of lipid digestion on gastric electrical activity in the cat
76. Reutericin 6, a new bacteriocin produced by Lactobacillus reuteri LA 6
77. Surface properties of lactobacilli isolated from the small intestine of pigs
78. Binding of Lactobacillus reuteri to fibronectin immobilized on glass beads
79. Autoaggregation of Lactobacillus reuteri is mediated by a putative DEAD-box helicase
80. Establishing a scientific basis for probiotic research and development
81. Characterization of the aggregation promoting factor from Lactobacillus gasseri, a vaginal isolate
82. High frequency of conjugation in Lactobacillus mediated by an aggregation-promoting factor
83. A collagen binding protein from Lactobacillus reuteri is part of an ABC transporter system
84. Purification of collagen-binding proteins of Lactobacillus reuteri
85. Mucus adhesion promoting protein of Lactobacillus reuteri 104R
86. Colonization by lactobacilli of piglet small intestinal mucus
87. Inhibition of adhesion of Escherichia coli K88 to piglet ileal mucus by Lactobacillus spp.
88. Purification and characterization of a compound produced by Lactobacillus fermentum that inhibits the adhesion of K88 expressing Escherichia coli to porcine ileal mucus
89. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans
90. Evidence of plasmid deoxyribonucleic acid in Lactobacillus
91. Drug resistant plasmids in Lactobacillus acidophilus and Lactobacillus reuteri
92. Conjugal transfer of broad-host-range plasmid pAMβl into enteric species of lactic acid bacteria
93. Conjugal transfer of plasmid pAMβ1 in Lactobacillus reuteri and between lactobacilli and Enterococcus faecalis
94. Lactobacillus protoplast transformation
95. Formation and regeneration of protoplasts and spheroplasts of gastrointestinal strains of lactobacilli
96. Transfer of plasmid pAMβ1 between members of the normal microflora inhabiting the murine digestive tract and modification of the plasmid in a Lactobacillus reuteri host
97. Exclusion of vanA, vanB and vanC type glycopeptide resistance in strains of Lactobacillus reuteri and Lactobacillus rhamnosus used as probiotics by polymerase chain reaction and hybridization methods
98. Identification and cloning of a plasmid-encoded erythromycin resistance determinant from Lactobacillus reuteri
99. Transformation of Lactobacillus reuteri with electroporation: Studies on the erythromycin resistance plasmid pLUL631
100. Molecular characterization of a plasmid-borne (pGT633) erythromycin resistance determinant (ermGT) from Lactobacillus reuteri
101. Molecular characterization of a plasmid-borne (pTC82) chloramphenicol resistance determinant (cat-TC) from Lactobacillus reuteri G4
102. Cloning of erythromycin-resistance determinants and replication origins from indigenous plasmids of Lactobacillus reuteri for potential use in construction of cloning vectors
103. Cloning of promoter-like sequences from Lactobacillus paracasei subsp. paracasei CG11 and their expression in Escherichia coli, Lactococcus lactis, and Lactobacillus reuteri
104. Single-stranded DNA plasmid, vector construction and cloning of Bacillus stearothermophilus alpha-amylase in Lactobacillus
105. Production of succinic acid from citric acid and related acids by Lactobacillus strains
106. Properties of acid ureases from Lactobacillus and Streptococcus strains
107. The formation of biogenic amines by fermentation organisms
108. Maltose phosphorylase and hexokinase activity in lactobacilli from traditionally prepared sourdoughs
109. Effect of environmental pH on the fermentation balance of Lactobacillus reuteri
110. Esterolytic and lipolytic activities of mesophilic and thermophilic lactobacilli
111. Release of spirosin associated with potassium phosphate-induced autolysis in Lactobacillus reuteri DSM 20016
112. Biochemical and structural characterization of the glucan and fructan exopolysaccharides synthesized by the Lactobacillus reuteri wild-type and by mutant strains
113. Stimulation of immunity by probiotics
114. The effect of probiotics on the gut micro-ecology of farm animals
115. Correlation of growth depression in chicks with the presence of Streptococcus faecium in the gut
116. Immunological consequences of changing environmental stimuli
117. Stress and immunity: An integrated view of relationships between the brain and the immune system
118. The effect of the intestinal flora on the growth rate of mice, and on their susceptibility to experimental infections
119. Heat-and cold-stress suppresses in vivo and in vitro cellular immune responses of chickens
120. Physiological stress in birds
121. Potential of probiotic organisms to prevent diarrhoea and promote digestion in farm animals-a review
122. Reserpine modification of blood pH, pCO2, and pO2 of chickens in high ambient temperature
123. Modification of corticosterone and glucose responses by sympatholytic agents in young chickens during acute heat exposure
124. Growth hormone and prolactin as natural antagonists of glucocorticoids in immunoregulation
125. Effects of stress on the immune system
126. What causes stress? Part 2 of the role of vitamin E
127. Probiotics
128. Stress affects disease outcomes
129. Influence of temperature on the immune response of birds
130. Probiotics: Intestinal inoculants for production animals
131. Evaluating poult growth and productivity during brooding
132. Poult growth depression costs industry big bucks
133. A mode of action of antibiotics in chicken nutrition
134. Influence of environment on the growth response of chicks to penìcillin
135. Observations on growth response to antibiotics and arsenic acids in poultry feeds
136. Environment and stimulation of growth of chickens by antibiotics
137. Immunologically mediated growth depression in chicks: Influence of feed intake, corticosterone and interleukin-1
138. Influence of cell sources, stimulating agents, and incubation conditions on release of interleukin-1 from chicken macrophages
139. Changes in protein degradation in chickens due to an inflammatory challenge
140. Changes in plasma, tissue, and urinary nitrogen metabolites due to an inflammatory challenge
141. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones
142. A complete regulatory loop between the immune and neuroendocrine systems
143. Effect of Lactobacillus reuteri on intestinal resistance to Cryptosporidium parvum infection in a murine model of acquired immunodeficiency syndrome
144. Cryptosporidium infection in an adult mouse model. Independent roles for IFN-gamma and CD4+ T lymphocytes in protective immunity
145. Requirements for CD4+ cells and gamma interferon in resolution of established Cryptosporidium parvum infection in mice
146. Gamma interferon functions in resistance to Cryptosporidium parvum infection in severe combined immunodeficient mice
147. Effect of lactobacilli on Cryptosporidium parvum infection in man and animals
148. Effects of Lactobacillus reuteri on Cryptosporidium parvum infection in gnotobiotic TCR-?-deficient mice
149. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice
150. Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice
151. Acetic acid-induced colitis in the rat: A reproducible experimental model for acute ulcerative colitis
152. Metabolism of arachidonic acid in acetic acid colitis in rats
153. Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat
154. The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic acid-induced colitis in the rat
155. Bacterial translocation of the gut flora
156. Gastrointestinal surface protection and mucosa reconditioning
157. Clinical uses of probiotics for stabilizing the gut mucosal barrier: Successful strains and future challenges
158. Bacterial overgrowth and intestinal atrophy in the etiology of gut barrier failure in the rat
159. The role of oral administration of oatmeal fermented by Lactobacillus reuteri R2LC on bacterial translocation after acute liver failure induced by subtotal liver resection in the rat
160. Effect of Lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the rat
161. The effect of pretreatment with endotoxin and Lactobacillus on bacterial translocation in acute liver injury
162. The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats
163. Intestinal immune response to oral administration of Lactobacillus reuteri R2LC, Lactobacillus plantarum DSM 9843, pectin and oatbase on methotrexate-induced enterocolitis in rats
164. Lactobacilli and bile salts hydrolase in the murine intestinal tract
165. Health and nutritional benefits from lactic acid bacteria
166. Cholesterol lowering and bile acid excretion in the hamster with cholestyramine treatment
167. Cholesterol lowering in pigs through enhanced bacterial bile salt hydrolase activity
168. Evidence for hypercholesterolemic effect of Lactobacillus reuteri in hypercholesterolemic mice
169. Helsinki heart study: Preliminary prevention trial with gemfibrozil in middle-age men with dislipemia
170. Lactobacilli inhabiting the digestive tract of mice do not influence serum cholesterol concentrations
171. Characterization and selection of probiotic lactobacilli for a preliminary minipig feeding trial and their effect on serum cholesterol levels, faeces pH and faeces moisture content
172. Effect of feeding of a cholesterol-reducing bacterium, Eubacterium coprostanoligenes, to germfree mice
173. Probiotic administrations of Lactobacillus reuteri protect mice from Salmonella typhimurium infection
174. Tolerance and fecal colonization with Lactobacillus reuteri in children fed a beverage with a mixture of Lactobacillus spp.
175. Safety and tolerance of Lactobacillus reuteri in healthy adult male subjects
176. Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus
177. Lactic acid bacteria in the gut in normal and disordered states
178. Ecological study on the intestinal bacterial flora of patients with diarrhea
179. Gut flora in normal and disordered states
180. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children
181. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain
182. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis
183. Controlled trial of orally administered lactobacilli in acute infantile diarrhea
184. Effect of an acidified milk on diarrhea and the carrier state in infants of low socio-economic stratum
185. Effect of feeding yogurt versus milk in children with persistent diarrhea
186. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children
187. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis
188. Feeding of a probiotic for the prevention of community-acquired diarrhea in young Mexican children
189. Feeding a Lactobacillus reuteri-containing probiotic drink for prevention of infantile diarrhea
190. Probiotics and the immune state
191. Ex vovo effects of lactobacilli, streptococci, and bifodobacteria ingestion on cytokine and nitric oxide production in a murine model
192. Effects of Lactobacillus reuteri on live performance and intestinal development of male turkeys
193. Lymphoid tissue and serum gamma globulin in young germfree chickens
194. Duodenal villus area and epithelial cellular migration in conventional and germfree chicks
195. Mathematical correlation between villus height and the nutritional state in Sprague-Dawley rats
196. Experimental studies in immunologically mediated enteropathy. I. Development of cell-mediated immunity and intestinal pathology during a graft-versus-host reaction in irradiated mice
197. Intestinal T lymphocytes
198. Changes in the rate of crypt epithelial cell proliferation and mucosal morphology induced by a T-cell-mediated response in human small intestine
199. Factors affecting the colonization of the gut by lactobacilli and other bacteria
200. Avian Salmonella-stained microtest antigen produced on solid media
201. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains
202. Use of intranasal IL-12 to target predominately Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin
203. A helminth-induced mucosal Th2 response alters nonresponsiveness to oral administration of a soluble antigen
204. Functional dairy foods, pros and cons. Probiotic cultures and conjugated linoleic acid are two functional components of dairy foods
205. Probiotic resolution
206. Effect of carbohydrates on Salmonella typhimurium colonization in broiler chickens
207. Effect of fructooligosaccharide on Salmonella colonization of the chicken intestine
208. Colonization control of lactose-fermenting Salmonella typhimurium in young broiler chickens by use of dietary lactose
209. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics
210. Functional dairy foods with Lactobacillus strain GG
211. The significance and potential molecular mechanisms of gastrointestinal barrier homeostasis
212. The use of probiotics to reinforce mucosal defense mechanisms
213. Probiotics in inflammatory bowel disease: New insight to pathogenesis or a possible therapeutic alternative?
214. Focus on health: Gut reactions
215. Functional foods: The western perspective
216. Enhancing the food supply
217. First international conference on east-west perspectives on functional foods
218. Antimicrobial components from lactic acid bacteria
219. Antigenotoxic properties of lactic acid bacteria in the S. typhimurium mutagenicity assay
220. Antimutagenic properties of probiotic bacteria and of organic acids
221. Cancer-preventive foods and ingredients
222. Marine oils: The health benefits of n-3 fatty acids
223. Dietary sources of conjugated dienoic isomers of linoleic acid, a newly recognized class of anticarcinogens
224. Conjugated linoleic acid (CLA)-producing bacteria: Isolation, identification, and properties of their linoleic acid isomerases
225. Conjugated linoleic acid: A powerful anticarcinogen from animal fat sources
226. Conjugated dienoic linoleate: A polyunsaturated fatty acid with unique chemoprotective properties
227. Cow's milk fat components as potential anticarcinogenic agents
228. Host-pathogen interactions: Redefining the basic concepts of virulence and pathogenicity
229. Probiotics in the new millennium
230. Protection against gastrointestinal diseases - Present facts and future developments
231. Purification and characterization of invertase from Lactobacillus reuteri CLR 1100
232. Evidence of a glucose proton motive force-dependent permease and a fructose phosphoenolpyruvate: Phosphotransferase transport system in Lactobacillus reuteri CRL 1098
233. Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of Cryptosporidium parvum oocytes in immunodeficient C57BL/6 mice